
USFDA APPLICATION NUMBER - 20591 / DOSAGE - TABLET, EXTENDED RELEASE;ORAL - 2MG;180MG
| Active Ingredient/Active Moiety | ||
| Ingredient Name | Basis of Strength | Strength |
|---|---|---|
| TRANDOLAPRIL(UNII: 1T0N3G9CRC) (TRANDOLAPRILAT - UNII:RR6866VL0O) | TRANDOLAPRIL | 4mg | 2mg | 1mg | 2mg |
| VERAPAMIL HYDROCHLORIDE (UNII: V3888OEY5R) (VERAPAMIL - UNII:CJ0O37KU29) | VERAPAMIL HYDROCHLORIDE | 240mg |
| VERAPAMIL HYDROCHLORIDE(UNII: V3888OEY5R) (VERAPAMIL - UNII:CJ0O37KU29) | VERAPAMIL HYDROCHLORIDE | 240mg | 240mg | 180mg |
Inactive Ingredients
| Ingredient Name | AbbVie Inc. | Greenstone LLC |
|---|---|---|
| ALCOHOL(3K9958V90M) | ||
| CELLULOSE, MICROCRYSTALLINE(OP1R32D61U) | ||
| DOCUSATE SODIUM(F05Q2T2JA0) | ||
| FERRIC OXIDE RED(1K09F3G675) | ||
| HYDROXYPROPYL CELLULOSE (1600000 WAMW)(RFW2ET671P) | ||
| HYPROMELLOSE, UNSPECIFIED(3NXW29V3WO) | ||
| LACTOSE MONOHYDRATE(EWQ57Q8I5X) | ||
| MAGNESIUM STEARATE(70097M6I30) | ||
| POLYETHYLENE GLYCOL, UNSPECIFIED(3WJQ0SDW1A) | ||
| POVIDONE, UNSPECIFIED(FZ989GH94E) | ||
| SILICON DIOXIDE(ETJ7Z6XBU4) | ||
| SODIUM ALGINATE(C269C4G2ZQ) | ||
| SODIUM STEARYL FUMARATE(7CV7WJK4UI) | ||
| STARCH, CORN(O8232NY3SJ) | ||
| TALC(7SEV7J4R1U) | ||
| TITANIUM DIOXIDE(15FIX9V2JP) | ||
| WATER(059QF0KO0R) |